Stay updated on ZPL389 Safety and Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the ZPL389 Safety and Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the ZPL389 Safety and Efficacy in Atopic Dermatitis Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedExpanded the list of study locations with new regional sections (e.g., Arizona, California, Ontario, Tokyo, Prague 1, Mazowian, SVK, etc.) and added a revision tag (v3.3.3); the HHS Vulnerability Disclosure link was removed.SummaryDifference1%

- Check56 days agoChange DetectedRevision history shows an addition of Revision: v3.3.2 and a removal of Revision: v3.2.0; no other study information appears to be altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedThe banner about government funding status and NIH operating status was removed. Core study information and links remain unchanged.SummaryDifference0.2%

- Check78 days agoChange DetectedNo significant changes to study content were detected; the updates appear to be non-substantive UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check107 days agoChange DetectedUpgrade to v3.2.0 with a new government-operational status notice; removes v3.1.0 and adds versioned update text and current operating status details.SummaryDifference3%

Stay in the know with updates to ZPL389 Safety and Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZPL389 Safety and Efficacy in Atopic Dermatitis Clinical Trial page.